Blood test for rheumatoid arthritis diagnosis
Part of Bones, joints & muscles, Immune system & allergy, Skin clinical trials.
This study is testing a new blood test that may help diagnose rheumatoid arthritis (RA) by detecting a specific antibody. If it works, it could lead to earlier and more accurate diagnosis.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be at least 18 years old.
- You are not diagnosed with another autoimmune disease, like lupus or scleroderma.
- You do not have a chronic infection or cancer.
- You are able to provide a blood sample for testing.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at whether a blood test can measure a protein linked to tissue scarring in people with rheumatoid arthritis or scleroderma. It aims to find a simpler way to track disease activity.
This study follows different groups of people—from those at high risk of developing rheumatoid arthritis to those recently diagnosed—to learn more about the disease. By joining, you help researchers understand who gets RA and why, which may lead to earlier detection and better care.
This study tests a smart home blood collection platform for people with rheumatoid arthritis. It aims to make remote monitoring easier by allowing you to collect blood samples at home using a smartphone or tablet.
This study looks at whether certain proteins (MMP-7 and MMP-9) in the blood can help identify lung problems in people with rheumatoid arthritis. It involves examining the tiny blood vessels at the base of your fingernails to see if they relate to these proteins.
This study looks at people with very early rheumatoid arthritis to see if a simple blood test and an ultrasound of the neck can show early signs of heart artery damage. The goal is to catch heart disease risk sooner in RA patients.
This trial aims to find out if a simple blood test (biomarker) can show whether a lower dose of rituximab will work for people with rheumatoid arthritis. If successful, it could help patients maintain good results with less medicine and fewer side effects.
Hear when a new Rheumatoid Arthritis (RA) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.